FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.’s Wishes
The peptides, which are increasingly marketed as providing longevity and health benefits, were removed in 2023 from the agency’s list of products that compounding pharmacies can sell.
- regulation and deregulation of industry
- drugs (pharmaceuticals)
- dietary supplements and herbal remedies
- black markets
- advertising and marketing
Source: www.nytimes.com
The peptides, which are increasingly marketed as providing longevity and health benefits, were removed in 2023 from the agency’s list of products that compounding pharmacies can sell.
